Categories: Health

KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025

RIYADH, Saudi Arabia, Sept. 10, 2025 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSHRC) led Saudi healthcare institutions in clinical trials, conducting 48% of all clinical trials registered nationwide during the first half of 2025, with 104 active clinical trials and 80 new studies underway, providing patients with broader access to innovative therapies and expanding future treatment options.

According to the Saudi National Institute of Health, clinical trials in the Kingdom during the first half of 2025 focused on cancer, cardiovascular diseases, musculoskeletal, dermatological and autoimmune conditions, gastrointestinal and liver diseases, as well as endocrine and metabolic disorders.

Among the most notable trials announced recently, KFSHRC reported the successful treatment of the first patient using genetically engineered CAR-T cells manufactured locally, as part of a Phase I clinical trial for patients with relapsed acute lymphoblastic leukemia—marking a milestone in the field of gene and cell therapies.

KFSHRC continues to strengthen its capabilities in advanced therapies, including gene and cellular treatments, while expanding into new clinical trials that drive medical innovation, reinforcing its role as a leader in pioneering healthcare research and aligning with the objectives of Saudi Vision 2030.

KFSHRC has been ranked first in the Middle East and Africa and 15th globally among the world’s top 250 Academic Medical Centres for 2025, in addition to being recognized as the most valuable healthcare brand in Saudi Arabia and the Middle East by Brand Finance in 2024, and listed among the World’s Best Smart Hospitals 2025 by Newsweek.

For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/46a67d93-6eb2-4bb6-ab9b-330a39ae59e4

GlobeNews Wire

Recent Posts

Cricketer Shreyas Iyer Unveils SoBo Mumbai Falcons Yoddhas Jersey and Flags Off 13 Player Contracts to Empower Emerging Talent

National cricket sensation Shreyas Iyer today unveiled the official jersey of SoBo Mumbai Falcons Yoddhas…

3 hours ago

Unlock Hidden Treasure in Book of Sands: Reborn Only on Parimatch

Parimatch, the #1 global gaming platform, proudly introduces its latest slot release, Book of Sands:…

3 hours ago

JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltne

SHANGHAI, Oct. 21, 2025 /PRNewswire/ -- China's leading multi-brand beauty group JOY GROUP (Shanghai Juyi Cosmetics Co.,…

3 hours ago

Virtuosi 2.0 – Unleashed

The Next Generation of BioPharma Education for the Advanced Manufacturing Era ALEXANDRIA, Va., Oct. 21,…

3 hours ago

The Shaw Prize Award Presentation Ceremony 2025: Continuing 22 Years of Legacy in Science and Innovation

HONG KONG, Oct. 21, 2025 /PRNewswire/ -- The Shaw Prize presented its awards to four…

4 hours ago

Netcracker Receives Frost & Sullivan’s 2025 Global and Regional Recognitions for OSS/BSS Technology Innovation, Product Leadership, and Company of the Year

Demonstrating unmatched OSS/BSS technology innovation, product leadership, and customer-centric excellence, Netcracker earns three Frost & Sullivan…

4 hours ago